Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Cagrilintide for Sale > Cagrilintide Long-Acting Amylin Analog High Purity Research Peptide CAS 1415456-99-3
Cagrilintide Long-Acting Amylin Analog High Purity Research Peptide CAS 1415456-99-3 buy - large image1
Cagrilintide Long-Acting Amylin Analog High Purity Research Peptide CAS 1415456-99-3 buy - image1
Cagrilintide Long-Acting Amylin Analog High Purity Research Peptide CAS 1415456-99-3 buy - image2
Cagrilintide Long-Acting Amylin Analog High Purity Research Peptide CAS 1415456-99-3 buy - image3
Cagrilintide Long-Acting Amylin Analog High Purity Research Peptide CAS 1415456-99-3 buy - image4
Cagrilintide Long-Acting Amylin Analog High Purity Research Peptide CAS 1415456-99-3 buy - image5
Cagrilintide Long-Acting Amylin Analog High Purity Research Peptide CAS 1415456-99-3 buy - image6

Cagrilintide Long-Acting Amylin Analog High Purity Research Peptide CAS 1415456-99-3

59 Inquiries

Unit Price:

$1.1/G FOB

Get Latest Price
CAS No.:

1415456-99-3

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Ningbo

Brand:

Ascent

Packaging:

5/10/15/20/30/60mg 10vials/box

Price valid (until):

2026-09-06

Company Type:
Trader
Location:
China
Qualification:
Main Products:

custom peptide

  • Product Description

  • Seller Information

  • History Price

  • Inquiry History

  • Description


      Product Detail  


    Cagrilintide (CAS 1415456-99-3) is a synthetic lipid-modified, long-acting amylin-analog research peptide. It is supplied for laboratories, biotechnology companies, contract research organizations, assay developers, and other professional research teams that need a clearly identified material. The main purchasing value is straightforward: receives a defined product name, molecular identity, agreed quality target, lot-specific documents, and packaging selected for the project.

    For routine research, a commonly requested purity target is at least 98% by chromatographic analysis, but the final agreed specification and actual result must appear on the certificate for the delivered lot. Buyers with concentration-sensitive work may also request information on content or assay basis, water, salt or counter-ion form, and other attributes relevant to their method.

    Cagrilintide is structurally more complex than a short linear peptide. Purchase specifications should clearly define the complete sequence, cyclic connection, terminal form, lipid modification, linker, salt form, purity method, mass confirmation, and content basis. A high purity percentage alone does not confirm that every structural element is correct.


    Shop Cagrilintide Long-Acting Amylin Analog High Purity Research Peptide CAS 1415456-99-3-Detailed Image 1 Shop Cagrilintide Long-Acting Amylin Analog High Purity Research Peptide CAS 1415456-99-3-Detailed Image 2

    Technical Data 
    Items Specifications
    Product Name

    Cagrilintid

    CAS

    1415456-99-

    Purity
    98%
    Sequence

    A 37-residue amylin-based sequence with a Cys2-Cys7 cyclic bridge, C-terminal amide, and C20 fatty-diacid modification through a gamma-Glu linker.

    Form
    Lyophilised Solid
    Molecular Formula

    C194H312N54O59S2


    How It Works

    Cagrilintide is engineered to interact with amylin-related receptor systems and to remain available longer than an unmodified peptide in research models. The lipid modification can increase association with albumin and slow removal or breakdown. Researchers study how these structural changes affect receptor activation, signal duration, stability, and metabolic-model outcomes.

    The material does not create one automatic or universal result. The observed response depends on the model, concentration, exposure time, controls, sample preparation, and measurement method. For that reason, it is best treated as a defined research input that helps a team test a question under controlled conditions.


    Common Research Applications

    Amylin-receptor assays. Used to compare binding and activation across amylin receptor subtypes and different receptor-component combinations.

    Calcitonin-receptor research. Supports comparative receptor-panel studies that examine selectivity, potency, response pattern, and model dependence.

    Long-acting peptide design. Useful for studying how lipid modification changes albumin association, enzymatic stability, exposure time, and apparent activity.

    Metabolic signaling models. Used in controlled preclinical models to examine feeding-related signals, energy-balance pathways, and glucose-related markers without assuming a clinical result.

    Combination-mechanism research. Can support model-based comparison of an amylin pathway alone or together with other defined research ligands.

    Structure-activity screening. Suitable for comparison with native amylin, other analogs, or modified sequences to understand how each design feature changes performance.


    Quality and Batch Documentation

    Quality should be judged from more than one number. Chromatographic analysis is used to estimate relative purity under a defined method. Mass analysis supports confirmation that the principal component has the expected molecular mass. Depending on the product and project, additional information may include appearance, content or assay basis, water, residual processing components, salt form, solution behavior, or other agreed tests.
    A useful lot package can include a Certificate of Analysis, chromatogram, mass spectrum, product name, CAS number, batch number, test date, storage statement, quantity basis, and release result. Buyers should request any special document or test before production or release, because not every optional test can be added after the material has shipped.
    HPLC and MS answer different questions. HPLC helps show how clean the sample appears in that test. MS helps show whether the main material has the expected mass. A high HPLC purity result does not replace identity confirmation, and an expected mass does not by itself describe the full purity profile.


    Handling and Storage

    Follow the certificate and label for storage. Lipid-modified peptides may show surface adsorption or concentration-dependent association, so keep the solvent system, container type, mixing procedure, and standing time consistent. Allow a cold sealed vial to warm before opening, prepare practical aliquots, and avoid repeated freeze-thaw cycles.

    The label and lot certificate take priority over general website text. If the planned method is sensitive to moisture, adsorption, light, temperature, or solution age, these conditions should be written into the laboratory procedure and kept consistent from one run to the next.


    Packaging, Supply, and Custom Options

    Packaging can be discussed according to project stage. Small packs are practical for feasibility work, while repeated studies may benefit from several matched units or material reserved from one lot. Larger research quantities, split filling, custom labeling, additional testing, or related sequence work can be reviewed before quotation. Feasibility, lead time, and price depend on the exact specification.

    A clear inquiry should include the product name, CAS number, required quantity, desired purity, preferred packaging, destination, document needs, and any special test. This reduces back-and-forth and helps the supplier quote the correct material rather than a similarly named product. If lot continuity is important, the expected total project demand should be discussed early.


    Why Choose This Product

    Clear identity. The product is described by its accepted name, CAS number, and relevant molecular information, reducing the risk of ordering a similarly named material.
    Practical quality evidence. A defined purity target can be combined with identity data and lot-specific documentation, giving the buyer more useful evidence than a purity claim alone.
    Flexible project support. Packaging, quantity, additional analysis, and related custom work can be discussed according to the research plan.
    Consistent communication. Product form, calculation basis, storage, documents, and special requirements can be confirmed before shipment so purchasing, quality, and research teams work from the same information.


    Shop Cagrilintide Long-Acting Amylin Analog High Purity Research Peptide CAS 1415456-99-3-Detailed Image 3

    Shop Cagrilintide Long-Acting Amylin Analog High Purity Research Peptide CAS 1415456-99-3-Detailed Image 4

    Shop Cagrilintide Long-Acting Amylin Analog High Purity Research Peptide CAS 1415456-99-3-Detailed Image 5


    Frequently Asked Questions

    What should be confirmed before ordering? Confirm the exact product name, CAS number, molecular form, required quantity, purity target, packaging, destination, and document list. For modified or species-specific materials, also confirm the complete sequence and modification pattern.

    Does 98% purity mean 98% active content? Not necessarily. Chromatographic purity is usually a relative peak-area result. Water, counter-ions, salts, and other non-volatile components may affect the weighed amount. Ask for the content basis when exact molar preparation is important.

    Which documents are commonly available? A lot-specific Certificate of Analysis is the main document. Supporting chromatographic and mass data can be discussed, together with any additional test agreed before release.

    Can the package size be customized? Yes, subject to material compatibility and production feasibility. Small research packs, multiple matched units, or larger research quantities can be reviewed during quotation.

    How should a working concentration be selected? There is no single concentration suitable for every model. Researchers should begin with relevant published methods or prior internal data, then perform a range study with suitable controls.

    How long can a prepared solution be kept? The answer depends on solvent, concentration, pH, temperature, light, container, and assay requirements. Use freshly prepared solution when possible or establish a validated holding period for the specific method.

    Why is the lot certificate important? The certificate connects the physical material to its batch number, test results, product form, and storage statement. General website information cannot replace the delivered lot record.

    Who is the intended customer? The material is intended for trained professionals in qualified laboratory, biotechnology, industrial research, academic, or contract research settings.

    Research-Use Statement

    This material is supplied solely for laboratory research and analytical work by trained professionals. It is not supplied for human or veterinary use, food use, household use, or diagnostic procedures. The purchaser is responsible for assessing suitability, reviewing the lot documents, establishing safe laboratory procedures, and following applicable institutional and local requirements.


    Cagrilintide is an amylin-analog, now being developed in combination with the GLP-1 agonist semaglutide to achieve sustained weight loss in persons with overweight and obesity. This drug is an investigational therapy that reduced body weight in a phase 2 trial when administered as monotherapy in participants without diabetes and with a BMI of at least 30 kg/m2 or at least 27 kg/m2 with hypertension or dyslipidaemia[1-2].

    Basic Info
    Product Name:

    Cagrilintide

    Other Name:

    Cagrilintide;Cargliptin;Caglitide;Cagrilintide acetate;Cagrilintide peptide;Cagrilintide 5mg 10mg 15mg;Cagrilintide(Acetate form);Kagliptin

    CAS No.:

    1415456-99-3

    Molecular Weight:

    0

    EC Number:

    206-141-6

    Color/Form:

    White to off-white

    Categories:

    Other Chemical Drugs

    Research
    Class:

    Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)

    Status:

    Investigational — Phase 3 (REDEFINE program, CagriSema combination)

    Mechanism:

    A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity. Administered once weekly.

    Activity note:

    Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.

    Source:

    MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.

    Clinical Development:

    NCT05249895; NCT05249882

    References
    PubChem:

    PubChem

    Disclaimer:

    Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    custom peptide

    Location:

    ROOM 203, 2ND FLOOR, BUILDING 2, NO. 265 CHENGRUI STREET, XIASHA STREET, QIANTANG DISTRICT, HANGZHOU CITY, ZHEJIANG PROVINCE,CHINA 310020

    Year of Establishment:

    2022

  • Weekly Price

    The chart shows the price trend of the product in the past 12 months.

  • Inquiry History
    59 Inquiries
    Country Product Purchase Quantity Date Posted
    United Kingdom

    Cagrilintide

    10 MG Jul 31, 2026
    France

    Cagrilintide

    10 MG May 22, 2026
    Australia

    Cagrilintide

    4 MT Mar 9, 2026
    United States

    Cagrilintide

    15 MG Feb 25, 2026
    United States

    Cagrilintide

    10 PCS Dec 27, 2025
    United States

    Cagrilintide

    2 MT Dec 21, 2025
    United States

    Cagrilintide

    100 MG Oct 28, 2025
    United States

    cagrilintide

    2 MT Aug 8, 2025
    Philippines

    Retatrutide

    5 MG Aug 5, 2025
    China

    Cagrilintide

    100 G May 6, 2025
    United States

    cagrilintide

    5 MG Feb 18, 2025
    United States

    Cagrilintide

    3 MT Feb 7, 2025
    United States

    Cagrilintide

    100  Nov 12, 2024
    United States

    Cagrillintide Lyophilized powder

    100 MG Jul 4, 2024
    United States

    Cagrillintide Lyophilized powder

    1000 MG Apr 20, 2024
    United States

    Cagrlintide

    1 MT Jul 31, 2026
    United Kingdom

    cagrilintrude

    20 MG Jul 21, 2026
    United States

    Cagrilintide

    1 KG Jul 17, 2026
    United States

    Cagrilintide

    30 MG May 26, 2026
    United Kingdom

    CAGRILLINTED

    10  May 3, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.